Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02039583
Other study ID # TRF NR-0166-1.2
Secondary ID
Status Completed
Phase N/A
First received January 16, 2014
Last updated January 16, 2014
Start date January 1995
Est. completion date January 2014

Study information

Verified date January 2014
Source University of Edinburgh
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate whether there has been a change in low birth weight and perinatal and infant mortality following the July 2007 introduction of a ban on smoking in public places and workplaces in England.


Description:

Primary research question Has there been a change in the numbers of babies being born with low birth weight or dying in the perinatal or infant period following the 1 July 2007 introduction of a ban on smoking in public places in England?

Study design Retrospective cohort study (using prospective routinely collected health care data)

Study population All singleton births in England between 1 January 1995 and 31 December 2011.

Intervention The intervention under study is the ban on smoking in enclosed public places and the workplace implemented in England overnight on 1 July 2007.

Inclusion and exclusion criteria We will include all registered singleton births in England occurring between 1 January 1995 and 31 December 2011. This is the maximum time period surrounding the ban's introduction for which the required birth data are available through the data source. Data were originally extracted for 1 January 1993 to 31 December 2011. However, postcode was not recorded in 1993-1994, leading to missing values for Index of Multiple Deprivation (IMD) quintile, region, and urbanisation level in this period. As these variables were considered key potential confounders in the primary analyses, a decision was made to restrict the modelling to the time period 1 January 1995-31 December 2011.

International Classification of Disease (ICD) coding changed from version 9 to 10 as of January 2001, leading to an important drop in recorded SIDS cases. Therefore, analyses of SIDS are restricted to the time period 2001-2011.

Babies with chromosomal anomalies will be excluded.

Outcome

The primary outcomes are:

- Low birth weight (birth weight < 2500 grams)

- Stillbirth (intrauterine death from 24+0 weeks gestation)

- Neonatal mortality (death within the first 28 days of life)

- Sudden infant death syndrome (SIDS; death within first year of life with mentioning on the death certificate of ICD-10-U code R95, or R99 with no other specification)

To assess whether smoke-free legislation had a selective impact on certain subgroups of outcomes we furthermore identified a number of secondary outcomes:

- Very low birth weight (birth weight < 1500 grams)

- Early neonatal mortality (death within first week of life)

- Late neonatal mortality (death between 7 and 28 days of life)

- Post-neonatal mortality (death between 28 days and 1 year of life)

- Infant mortality (death within the first year of life)

Data sources Data are obtained via the Office for National Statistics (ONS). All registered stillbirths and livebirths occurring in England between 1 January 1995 and 31 December 2011 are included. These are linked to death certificates for all deaths occurring before the first birthday.

Data extraction and handling Individual perinatal and mortality data are linked by ONS in a single database including the following individual-level covariates: month of birth, year of birth, month of death, year of death, age at death, sex, birth weight, maternal age, maternal marital status, parity, IMD, region, urbanisation level.

The following covariates are categorised for information governance reasons:

- Age at death: early neonatal, late neonatal, post-neonatal

- Birth weight: <1000 grams, 1000-1499 grams, 1500-2499 grams, 2500-3999 grams, ≥4000 grams

- Maternal age: <20 years, 20-24 years, 25-29 years, 30-34 years, 35-39 years, >40 years

- Parity: 0, 1, 2, ≥3

- IMD: quintiles

- Region: 10 regions

- Urbanisation level: urban, rural

Sample size Sample size calculation for time-oriented analyses is complicated given the complexity of the models. We will use national data for the current study, which will - to the best of our knowledge - be the largest evaluation of the impact of smoke-free legislation on perinatal health, both regarding population size and time span. As we use the maximum time span and population available, sample size calculation can in a way be considered redundant.

We are aware of only one published study on smoke-free legislation and early-life mortality (reference 1). Due to design issues it is not possible to involve data from this study for comparison to the current study.

A number of studies have previously assessed the impact of smoke-free legislation on low birth weight. Our proposed approach is best comparable to that performed earlier in Scotland (reference 2). Using Scottish data on 757,795 deliveries occurring between 1996 and 2009, they showed an immediate -9.9% (95%CI -14.2; -5.2) drop in low-birth-weight-babies. Given the longer study period (1993-2011) and the much larger population size (n>10 million) our study can be expected to have sufficient power to detect a similar reduction in low-birth-weight-babies in England, if present.

Statistical analysis

Relevant population characteristics will be described. Logistic regression analysis will be performed to investigate the association between introduction of smoke-free legislation and sudden ('step') and/or gradual ('slope') changes (as appropriate) in the odds of developing each outcome. Analyses will be adjusted for birth weight, sex, maternal age, maternal marital status, parity (secondary analyses only, see below), IMD quintile, region, and urbanisation level. Seasonal patterning and non-linearity of the underlying time trend will be accounted for as appropriate. Final model selection will be based on Akaike's and Bayesian information criteria (AIC and BIC). The denominator for the analyses will differ according to the various outcomes:

- stillbirths: all births in the dataset

- low birth weight, very low birth weight, neonatal mortality, early neonatal mortality, infant mortality: all livebirths in the dataset

- late neonatal mortality: all livebirths in the dataset surviving the early neonatal period

- post-neonatal mortality: all livebirths in the dataset surviving the neonatal period

The primary analyses will be performed on cases with complete data on all covariates. Parity is the only variable that has >10% missing data (approximately 40-50%), as it is only recorded in married women. As parity is not expected to be a key confounder, we will perform the primary analyses without involving parity in the models in order to maximise population size.

Sensitivity analyses To assess possible confounding by parity, sensitivity analyses will be performed that include parity in the model. In a second set of sensitivity analyses, imputation will be performed to investigate the robustness of the findings to missing data. In order to minimise issues regarding multiple testing, sensitivity analyses will be performed for the primary outcomes only.

All analyses will be performed using Stata 12.0.


Recruitment information / eligibility

Status Completed
Enrollment 10291118
Est. completion date January 2014
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 1 Year
Eligibility Inclusion Criteria:

- singleton birth occurring in England between 1 January 1995 and 31 December 2011

Exclusion Criteria:

- chromosomal anomalies

- stillbirth (applies to all outcomes other than stillbirth)

Study Design

Observational Model: Ecologic or Community


Intervention

Other:
Smoke-free legislation
The intervention under study is the smoke-free legislation in England introduced overnight on 1 July 2007. As of this date virtually all enclosed public places and workplaces were by law required to be smoke-free. More detail can be found via the link provided at the end of this protocol.

Locations

Country Name City State
United Kingdom University of Edinburgh Edinburgh Midlothian

Sponsors (4)

Lead Sponsor Collaborator
University of Edinburgh Imperial College London, Maastricht University, Maastricht, Netherlands, University of Glasgow

Country where clinical trial is conducted

United Kingdom, 

References & Publications (3)

Mackay DF, Nelson SM, Haw SJ, Pell JP. Impact of Scotland's smoke-free legislation on pregnancy complications: retrospective cohort study. PLoS Med. 2012;9(3):e1001175. doi: 10.1371/journal.pmed.1001175. Epub 2012 Mar 6. — View Citation

Markowitz S. The effectiveness of cigarette regulations in reducing cases of Sudden Infant Death Syndrome. J Health Econ. 2008 Jan;27(1):106-33. Epub 2007 Apr 8. — View Citation

Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011 Jan 8;377(9760):139-46. doi: 10.1016/S0140-6736(10)61388-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary low birth weight birth weight <2,500 grams 1 Jan 1995 - 31 Dec 2011 No
Primary stillbirth intrauterine death from 24+0 weeks gestation 1 Jan 1995 - 31 Dec 2011 No
Primary neonatal mortality death within the first 28 days of life 1 Jan 1995 - 31 Dec 2011 No
Primary sudden infant death syndrome (SIDS) death within first year of life with mentioning on the death certificate of ICD-10-U code R95, or R99 with no other specification 1 Jan 2001 - 31 Dec 2011 No
Secondary very low birth weight birth weight < 1,500 grams 1 Jan 1995 - 31 Dec 2011 No
Secondary early neonatal mortality death within the first week of life 1 Jan 1995 - 31 Dec 2011 No
Secondary late neonatal mortality death between 7 and 28 days of life 1 Jan 1995 - 31 Dec 2011 No
Secondary post-neonatal mortality death between 28 days and 1 year of life 1 Jan 1995 - 31 Dec 2011 No
See also
  Status Clinical Trial Phase
Recruiting NCT03605511 - TTP and aHUS in Complicated Pregnancies
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A
Not yet recruiting NCT01664546 - Study of the Best Blastocyst Post Transfer by aCGH N/A
Completed NCT02218931 - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes N/A
Recruiting NCT03662178 - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Completed NCT03290924 - Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach N/A
Recruiting NCT05901688 - Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
Completed NCT02339077 - Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
Completed NCT03112018 - Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda N/A
Completed NCT02862925 - Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings. N/A
Completed NCT02318420 - The PartoMa Project: For Improving Monitoring, Action and Triage During Labour N/A
Recruiting NCT05757167 - Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics Phase 4
Completed NCT02148952 - BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program N/A
Active, not recruiting NCT01995968 - Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate. N/A
Completed NCT00270530 - Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia Phase 4
Completed NCT04600076 - MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers N/A
Completed NCT03363308 - Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa N/A
Completed NCT03722615 - Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
Completed NCT02907242 - Revealed Versus Concealed Cerebroplacental Ratio N/A
Recruiting NCT02336243 - A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders Phase 3

External Links